Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Findings advance knowledge in breast cancer research
June 23rd, 2005
Reports from Finland, the South Korea and the United States highlight recent research on breast cancer. Study 1: The n-acetyltransferase 2 slow acetylator genotype may be a key modifier of environmentally-induced breast cancer risk in Finnish women. "N-acetyltransferase 2 (NAT2) is a polymorphic enzyme participating in the metabolism of numerous pharmaceutical drugs and carcinogens found in tobacco smoke and diet. The NAT2 gene is highly polymorphic and several different allelic variants exist that determine the acetylator phenotype," wrote P. Sillanpaa and colleagues, Finnish Institute of Occupational Health, Helsinki. "In the...
Source: Women's Health Weekly (2005-06-23)
|
